Through our thought leadership efforts, we inform and influence policy outcomes to ultimately improve access to healthcare and enhance societal wellbeing. Our professionals regularly author and publish peer-reviewed articles, research reports, commentaries, opinion pieces, and whitepapers.
Recent Peer-Reviewed Articles:
July 2019 - The Journal of the Economics of Ageing:
Indirect costs of adult pneumococcal disease and productivity-based rate of return to PCV13 vaccination for older adults and elderly diabetics in Denmark [Read More]
July 2019 - Human Vaccines & Immunotherapeutics:
Indirect costs of adult pneumococcal disease and productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey [Read More]